Savara to present at the jefferies healthcare conference

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the jefferies healthcare conference on june 9, 2023 at 10:30 am et/7:30 am pt. a live webcast of the fireside chat will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. about savara savara is a clinical s.
SVRA Ratings Summary
SVRA Quant Ranking